The best-performing stock of the past 20 years is not Apple, Microsoft, or Berkshire Hathaway. It’s Monster Beverage Corp! This energy drink, a favorite of developers and gamers, started as fresh fruit juice and, after a radical transformation, rose to a 20-year trailing total return of 87,560%. So, it’s never too late to turn around your image.
Start from $10, earn to $1000
There are dozens of prospective companies that may be flying under your radar, like MNST. Let’s change that. The following list of 10 companies to watch is based on scenarios from Bloomberg Intelligence analysts.
1. Aker BP, energy
- Market value: $18 billion
- Sales, last 12 months: $8 billion
- Expected 2023 revenue growth: 20%
The Norwegian North Sea oil producer’s cash flows are benefiting from elevated Brent crude prices. Over the past year, earnings grew by 163.8%, and analysts might exceed expectations next year as well. The acquisition of Lundin Energy’s E&P business this year is another reason for growing free cash flow and subsequently increasing returns to shareholders.
Effective strategies in your mailbox
Subscribe and discover a fund of trading knowledge
Great! Please check your email
We’ve sent you an email to confirm your subscription
Something went wrong
Try reloading the page. If that doesn’t help, please try again later
2. Brown-Forman, beverages
- Market value: $32 billion
- Sales, last 12 months: $4 billion
- Expected 2023 revenue growth: 5%
The maker of Jack Daniel’s is getting a boost in revenue thanks to bars and restaurants thriving again.
Market studies show that people are more likely to buy premium spirits in clubs and pubs than for house events. So, rising nightlife traffic will contribute to positive earnings surprises, beating the consensus for fiscal 2023 sales.
3. CF Industries, fertilizers
- Market value: $19 billion
- Sales, last 12 months: $10 billion
- Expected 2023 revenue growth: 18%
Fertilizer prices have risen by 30% since the start of 2022, and companies like CF Industries are seeing the results in stronger-than-anticipated profits. Even when prices drop from record levels, they are likely to stay elevated. Due to the current situation, US-based low-cost producers are poised for growth.
Top 5 sitting postures for traders
Many traders think less about their sitting postures, negatively impacting their health. Check it out!
Read more
4. China Gas, utilities
- Market value: $6 billion
- Sales, last 12 months: $11 billion
- Expected 2023 revenue growth: 16%
Domestically, China’s LNG winter demand is predicted to decline modestly by 1.5% compared to last year. As for exports, prices are expected to remain elevated for the rest of this year and Q1-Q2 2023. With a steady demand, retail volumes growing, and selling prices rising, the profit margins will be going up.
Earn profit in 1 minute
5. Emerson, industrials
- Market value: $44 billion
- Sales, last 12 months: $19 billion
- Expected 2023 revenue growth: 5%
The electrical equipment maker is reaping the rewards from robust energy markets. High energy prices serve as another boost for the company, which doesn’t seem to be changing this year or the next.
To make matters better, Emerson launched a multiyear financial restructuring to welcome above-consensus sales and rising profit margins.
6. Freshpet, pet food
- Market value: $2 billion
- Sales, last 12 months: $0.5 billion
- Expected 2023 revenue growth: 29%
Freshpet is making a name for itself in the pet economy, in a niche barely occupied by other companies. There isn’t much competition for fresh, refrigerated food for cats and dogs, but the demand from pet owners seems to be higher than ever.
Management’s goal in sales may be too modest, considering the recent changes that extend the company’s production capacity sixfold.
7. Idorsia, biotech
- Market value: $2 billion
- Sales, last 12 months: $45 billion
- Expected 2023 revenue growth: 191%
In 2022, the FDA approved Idorsia’s first drug, Quviviq, for the treatment of adults with insomnia. The drug is also as safe as a placebo in terms of the most common reported adverse reactions, which may make a splash in the market. While the success didn’t come immediately after approval, the Swiss biotech company is looking good in most projections.
8. Meta, internet
- Market value: $366 billion
- Sales, last 12 months: $119 billion
- Expected 2023 revenue growth: 10%
The stock has dropped by more than half in 2022 thus far (from over $300 per share to under $150). But this may be the starting point for recovery. The two catalysts investors would pay attention to are the faster-than-expected pace of monetization for Reels and headcount growth.
9. Rongsheng, chemicals
- Market value: $19 billion
- Sales, last 12 months: $37 billion
- Expected 2023 revenue growth: 13%
The plastic maker is about to increase production. As part of Rongsheng’s ambitious expansion plans, the two additional facilities—new ethylene cracker complexes—are expected to triple the company’s exposure to a certain type of higher-end plastics. Analysts believe these changes are bound to increase the company’s market share.
10. UniCredit, banks
- Market value: $20 billion
- Sales, last 12 months: $21 billion
- Expected 2023 revenue growth: 1%
Internal revenue projections appear too cautious, according to Bloomberg Intelligence. UniCredit has a number of strengths, including a strong capital buffer, net interest income growth, and favorable asset quality trends. Together, they make a case for a marginally higher valuation for the next year.
Takeaway
These ten companies are set for success thanks to their current financials, favorable trends, and projected economic events. Of course, these are not the only stocks that will prosper this and next year, so don’t stop your research here.
Keep in mind that a prediction of an upwards trajectory is not a guarantee.
Trading with up to 90% profit
<span>Like</span>
5 min 
